ShareValue scores for OACC: Valuation 33, Quality 50, Growth 57, Health 48.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share logo

OACC
NASDAQ

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

$10.74(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-5% to 10%
Valuation
33
Overvalued
Price vs Value
Quality
50
Moderate
Business Strength
Growth
57
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
51
Neutral
Price Trend

Company Details

About

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026